These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Tumor-intrinsic signaling pathways: key roles in the regulation of the immunosuppressive tumor microenvironment. Yang L; Li A; Lei Q; Zhang Y J Hematol Oncol; 2019 Nov; 12(1):125. PubMed ID: 31775797 [TBL] [Abstract][Full Text] [Related]
4. Biomedicine. Cancer therapies use a little help from microbial friends. Pennisi E Science; 2013 Nov; 342(6161):921. PubMed ID: 24264971 [No Abstract] [Full Text] [Related]
5. Gut microbiota: Anti-cancer therapies affected by gut microbiota. Greenhill C Nat Rev Gastroenterol Hepatol; 2014 Jan; 11(1):1. PubMed ID: 24322902 [No Abstract] [Full Text] [Related]
7. Targeting the tumor microenvironment by immunotherapy: part 2. Leibovici J; Itzhaki O; Huszar M; Sinai J Immunotherapy; 2011 Nov; 3(11):1385-408. PubMed ID: 22053888 [TBL] [Abstract][Full Text] [Related]
8. Chemotherapy, immunity and microbiota--a new triumvirate? Karin M; Jobin C; Balkwill F Nat Med; 2014 Feb; 20(2):126-7. PubMed ID: 24504404 [TBL] [Abstract][Full Text] [Related]
9. Cancer, obesity and immunometabolism - Connecting the dots. Dyck L; Lynch L Cancer Lett; 2018 Mar; 417():11-20. PubMed ID: 29253522 [No Abstract] [Full Text] [Related]
11. [Mechanism of action for immunotherapy drugs]. Tahara H Nihon Rinsho; 2012 Dec; 70(12):2066-72. PubMed ID: 23259376 [TBL] [Abstract][Full Text] [Related]
12. Impact of tumor microenvironment composition on therapeutic responses and clinical outcomes in cancer. Anari F; Ramamurthy C; Zibelman M Future Oncol; 2018 Jun; 14(14):1409-1421. PubMed ID: 29848096 [TBL] [Abstract][Full Text] [Related]
13. [Molecular targets for development of cancer immunotherapy]. Kawakami Y Nihon Rinsho; 2012 Nov; 70 Suppl 8():144-8. PubMed ID: 23513828 [No Abstract] [Full Text] [Related]
14. Shaping of an effective immune microenvironment to and by cancer cells. Becht E; Goc J; Germain C; Giraldo NA; Dieu-Nosjean MC; Sautès-Fridman C; Fridman WH Cancer Immunol Immunother; 2014 Oct; 63(10):991-7. PubMed ID: 25112529 [TBL] [Abstract][Full Text] [Related]
15. Immunosuppression in the tumor microenvironment: where are we standing? Umansky V Semin Cancer Biol; 2012 Aug; 22(4):273-4. PubMed ID: 22709654 [No Abstract] [Full Text] [Related]
16. Nanomaterials for cancer immunotherapy. Song W; Musetti SN; Huang L Biomaterials; 2017 Dec; 148():16-30. PubMed ID: 28961532 [TBL] [Abstract][Full Text] [Related]
17. [Immunology and personalized medicine in oncology]. Zinzindohoué F; Zeitoun G; Berger A; Todosi AM; Marliot F; Lagorce C; Galon J; Pagès F Bull Cancer; 2014 Jun; 101 Suppl 1():S12-7. PubMed ID: 24966077 [TBL] [Abstract][Full Text] [Related]